With in-person business development events being a rare undertaking these days the euroPLX 78 Lisbon Marketplace for Pharma Business Opportunities stuck out with almost 400 out of 425 Business Development Executives having been present physically on 4 and 5 April in the coastal town of Cascais close to Lisbon, Portugal. Only 6% opted for digital-only negotiations which the seamlessly integrated video facility allows among all participants before and after the on-site event.
The Business Development Executives representing 257 pharmaceutical companies from 41 countries were having pre-scheduled 5,481 on-site business development negotiations (with face masks) on two days and are still continuing with several thousand digital business meetings until April 19.
Stefan Hilscher, one of the Managing Directors of the Heidelberg, Germany, based service provider RauCon GmbH & Co. points out: „Over almost 27 years, RauCon’s Marketplaces for Pharma Business Opportunities have become the indispensable business development platform for a hundreds of returning attendees. More than 170 Business Development Executives from all over the world have already attended more than 10 times, 45 more than 20 times, 16 more than 30 times, and two even more than 40 times. There is no other pharma or biotech partnering event with such a track record.“
The Business Development Executives representing 257 pharmaceutical companies from 41 countries were having pre-scheduled 5,481 on-site business development negotiations (with face masks) on two days and are still continuing with several thousand digital business meetings until April 19.
Stefan Hilscher, one of the Managing Directors of the Heidelberg, Germany, based service provider RauCon GmbH & Co. points out: „Over almost 27 years, RauCon’s Marketplaces for Pharma Business Opportunities have become the indispensable business development platform for a hundreds of returning attendees. More than 170 Business Development Executives from all over the world have already attended more than 10 times, 45 more than 20 times, 16 more than 30 times, and two even more than 40 times. There is no other pharma or biotech partnering event with such a track record.“
